Jack O’Brien talks with Moderna’s Kate Cronin about how she’s working to equate the Cambridge company with disease areas beyond COVID, and we share policy and social media updates.
Fear of greenwashing label stops influencers discussing sustainability, Unilever study finds
This is a return to the top of the leaderboard for Skyrizi, which is always in the running for the Rx and OTC pharma brand crown but has only been ranked first on a monthly basis once this year.
Drugmakers in crowded immunology space ramp up branded push
In recent months, many brand controversies have been rooted in misinformation and false allegations. But experts say it’s not always imperative to right those wrongs.
The “honeymoon phase is over” for Threads — here are the features that could bring brands back